Junjie Chen Selected Research

Pinacidil (Pindac)

7/2015	Effects of pinacidil on changes to the microenvironment around the incision site, of a skin/muscle incision and retraction, in a rat model of postoperative pain.
5/2015	Effect of adenosine triphosphate-sensitive potassium activation on peripheral and central pain sensitization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junjie Chen Research Topics

Disease

92	Neoplasms (Cancer) 10/2022 - 04/2003
17	Ataxia Telangiectasia (Louis Bar Syndrome) 11/2020 - 01/2002
16	Breast Neoplasms (Breast Cancer) 10/2021 - 03/2002
15	Genomic Instability 01/2017 - 07/2005
11	Inflammation (Inflammations) 02/2022 - 09/2008
11	Carcinogenesis 01/2021 - 11/2005
11	Fanconi Anemia (Fanconi's Anemia) 12/2020 - 04/2005
10	Cicatrix (Scar) 06/2022 - 01/2005
10	Neoplasm Metastasis (Metastasis) 01/2022 - 12/2014
10	Keloid 11/2021 - 08/2005
8	Pain (Aches) 06/2022 - 05/2015
8	Lung Neoplasms (Lung Cancer) 01/2019 - 09/2015
7	Colorectal Neoplasms (Colorectal Cancer) 10/2022 - 01/2015
5	Lung Injury 04/2022 - 01/2016
5	Hypoxia (Hypoxemia) 09/2020 - 06/2010
5	Fibrosis (Cirrhosis) 10/2019 - 03/2009
4	Hypertrophic Cicatrix (Hypertrophic Scar) 12/2021 - 08/2005
4	Carcinoma (Carcinomatosis) 01/2021 - 04/2010
4	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2020
4	Burns 06/2019 - 02/2013
3	Infections 10/2022 - 01/2021
3	Hyperplasia 05/2022 - 11/2019
3	Reperfusion Injury 02/2022 - 04/2015
3	Adenocarcinoma 01/2022 - 01/2019
3	Melanoma (Melanoma, Malignant) 01/2022 - 06/2018
3	Hyperalgesia 01/2022 - 05/2015
3	Infarction (Infarctions) 01/2022 - 09/2003
3	Wounds and Injuries (Trauma) 11/2021 - 02/2013
3	Acute Lung Injury 06/2021 - 01/2014
3	Hemorrhage 04/2021 - 01/2019
3	Thrombosis (Thrombus) 01/2019 - 08/2003
3	Ovarian Neoplasms (Ovarian Cancer) 04/2018 - 02/2010
3	Lymphoma (Lymphomas) 04/2018 - 11/2005
3	Hypersensitivity (Allergy) 12/2017 - 03/2010
3	Nijmegen Breakage Syndrome 08/2008 - 01/2007
2	Bites and Stings (Sting) 10/2022 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 09/2022 - 01/2021
2	Cleft Lip (Harelip) 06/2022 - 01/2021
2	Osteoarthritis 06/2022 - 01/2021
2	Ischemia 02/2022 - 04/2015
2	Lymphatic Metastasis 01/2022 - 10/2020
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2021 - 12/2017
2	Postoperative Pain 11/2021 - 07/2015
2	Colonic Neoplasms (Colon Cancer) 10/2021 - 01/2017
2	Edema (Dropsy) 06/2021 - 01/2014

Drug/Important Bio-Agent (IBA)

51	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
24	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2002
15	Pharmaceutical PreparationsIBA 10/2022 - 12/2009
14	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2012
9	MicroRNAs (MicroRNA)IBA 01/2022 - 12/2014
9	Phosphotransferases (Kinase)IBA 11/2020 - 12/2002
7	Long Noncoding RNAIBA 01/2022 - 01/2016
7	Biological ProductsIBA 01/2022 - 08/2009
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 05/2015
6	Carrier Proteins (Binding Protein)IBA 01/2022 - 04/2003
6	CollagenIBA 11/2021 - 01/2005
6	Messenger RNA (mRNA)IBA 05/2021 - 08/2005
6	FluorocarbonsIBA 01/2018 - 09/2008
5	Aurora KinasesIBA 01/2022 - 04/2005
5	Histones (Histone)IBA 04/2010 - 11/2004
4	Particulate MatterIBA 04/2022 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2015
4	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021 - 11/2005
4	CateninsIBA 12/2020 - 11/2018
4	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019 - 05/2016
4	Sirtuin 1IBA 06/2010 - 01/2008
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 06/2021
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2021
3	EnzymesIBA 01/2022 - 04/2008
3	Sirolimus (Rapamycin)FDA Link 01/2022 - 05/2014
3	AutoantibodiesIBA 12/2021 - 12/2016
3	LigandsIBA 02/2021 - 11/2013
3	RNA (Ribonucleic Acid)IBA 01/2021 - 02/2013
3	Checkpoint Kinase 1IBA 01/2020 - 06/2003
3	Protein Kinases (Protein Kinase)IBA 01/2019 - 12/2005
3	UbiquitinIBA 05/2018 - 12/2009
3	HSP47 Heat-Shock Proteins (Heat Shock Protein 47)IBA 12/2016 - 01/2005
3	ChromatinIBA 01/2015 - 03/2010
3	pleiotrophin (HARP)IBA 06/2011 - 12/2004
3	Checkpoint Kinase 2IBA 08/2006 - 09/2003
2	AntigensIBA 10/2022 - 12/2016
2	Oxygen (Dioxygen)IBA 05/2022 - 07/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2022 - 06/2015
2	CytokinesIBA 04/2022 - 03/2016
2	SolutionsIBA 02/2022 - 07/2013
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 11/2021
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 01/2015
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2019
2	Methotrexate (Mexate)FDA LinkGeneric 01/2022 - 02/2017
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 02/2017
2	Estrogens (Estrogen)FDA Link 01/2022 - 02/2021
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 09/2014
2	TOR Serine-Threonine KinasesIBA 11/2021 - 01/2020
2	Formaldehyde (Formol)FDA Link 06/2021 - 09/2003

Therapy/Procedure

42	Therapeutics 10/2022 - 09/2008
5	Radiotherapy 10/2022 - 01/2018
3	Aftercare (After-Treatment) 01/2022 - 04/2005
2	Acupuncture Therapy 01/2022 - 01/2022
2	Immunotherapy 01/2022 - 10/2021
2	Precision Medicine 10/2021 - 01/2021